Adhiraj Roy1, Gopeshwar Narayan2. 1. Interdisciplinary School of Life Sciences, Institute of Science, Banaras Hindu University, Varanasi, 221005, India. adhiraj.roy@yahoo.com. 2. Department of Molecular and Human Genetics, Institute of Science, Banaras Hindu University, Varanasi, India.
Abstract
INTRODUCTION: The nuclear pore complex is comprised of approximately 30 proteins named nucleoporins (Nups) and tightly regulates nucleocytoplasmic transport of macromolecules across the nuclear membrane. Genetic alterations in many NUP genes are associated with many human maladies, such as neurological disease, autoimmune disorders and cancer. METHODS: We reviewed the status quo of recent advancement of the knowledge of oncogenic role of nucleoporins in human carcinogenesis, focusing on major non-hematological malignancies in the recent literature. Both clinical study-derived and experiment-based reports were critically reviewed. We have also discussed the potential of nucleoporins as novel cancer biomarkers and promising therapeutic target against human malignancies. RESULTS: Several Nups such as Nup53, Nup88, Nup98, Nup160 and Nup214 modulated a plethora of cellular and physiological pathways involved in tumorigenesis such as GSK3β-Snail, Wnt/β-Catenin and RanGap1/RanBP2 signaling axes, DNA damage response, resistance to apoptosis and chemotherapy. CONCLUSION: Although classically, majority of studies have shown oncogenic roles of nucleoporins as genetic fusion partners in several types of leukemia, emerging evidence suggests that nucleoporins also modulate many cellular signaling pathways that are associated with several major non-hematological malignancies, such as carcinomas of skin, breast, lung, prostate and colon. Hence, nucleoporins are emerging as novel therapeutic targets in human tumors.
INTRODUCTION: The nuclear pore complex is comprised of approximately 30 proteins named nucleoporins (Nups) and tightly regulates nucleocytoplasmic transport of macromolecules across the nuclear membrane. Genetic alterations in many NUP genes are associated with many human maladies, such as neurological disease, autoimmune disorders and cancer. METHODS: We reviewed the status quo of recent advancement of the knowledge of oncogenic role of nucleoporins in humancarcinogenesis, focusing on major non-hematological malignancies in the recent literature. Both clinical study-derived and experiment-based reports were critically reviewed. We have also discussed the potential of nucleoporins as novel cancer biomarkers and promising therapeutic target against humanmalignancies. RESULTS: Several Nups such as Nup53, Nup88, Nup98, Nup160 and Nup214 modulated a plethora of cellular and physiological pathways involved in tumorigenesis such as GSK3β-Snail, Wnt/β-Catenin and RanGap1/RanBP2 signaling axes, DNA damage response, resistance to apoptosis and chemotherapy. CONCLUSION: Although classically, majority of studies have shown oncogenic roles of nucleoporins as genetic fusion partners in several types of leukemia, emerging evidence suggests that nucleoporins also modulate many cellular signaling pathways that are associated with several major non-hematological malignancies, such as carcinomas of skin, breast, lung, prostate and colon. Hence, nucleoporins are emerging as novel therapeutic targets in humantumors.
Authors: Nozomi Takahashi; Jeroen W J van Kilsdonk; Benedikt Ostendorf; Ruben Smeets; Sophia W M Bruggeman; Angel Alonso; Fons van de Loo; Matthias Schneider; Wim B van den Berg; Guido W M Swart Journal: Biochem Biophys Res Commun Date: 2008-07-11 Impact factor: 3.575
Authors: Loukia G Karacosta; Laura A Kuroski; Wilma A Hofmann; Gissou Azabdaftari; Michalis Mastri; Angela M Gocher; Shuhang Dai; Allen J Hoste; Arthur M Edelman Journal: Prostate Date: 2015-11-10 Impact factor: 4.104
Authors: Ajai J Pulianmackal; Kiriaki Kanakousaki; Kerry Flegel; Olga G Grushko; Ella Gourley; Emily Rozich; Laura A Buttitta Journal: Dis Model Mech Date: 2022-03-16 Impact factor: 5.758